Shanghai Rongtai Health Tech (603579) - Net Assets
Based on the latest financial reports, Shanghai Rongtai Health Tech (603579) has net assets worth CN¥2.75 Billion CNY (≈ $402.64 Million USD) as of September 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥3.35 Billion ≈ $489.91 Million USD) and total liabilities (CN¥596.42 Million ≈ $87.28 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Shanghai Rongtai Health Tech asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥2.75 Billion |
| % of Total Assets | 82.19% |
| Annual Growth Rate | 23.23% |
| 5-Year Change | 22.14% |
| 10-Year Change | 544.44% |
| Growth Volatility | 53.76 |
Shanghai Rongtai Health Tech - Net Assets Trend (2011–2024)
This chart illustrates how Shanghai Rongtai Health Tech's net assets have evolved over time, based on quarterly financial data. Also explore how large is Shanghai Rongtai Health Tech's balance sheet for the complete picture of this company's asset base.
Annual Net Assets for Shanghai Rongtai Health Tech (2011–2024)
The table below shows the annual net assets of Shanghai Rongtai Health Tech from 2011 to 2024. For live valuation and market cap data, see Shanghai Rongtai Health Tech (603579) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | CN¥2.02 Billion ≈ $294.95 Million |
+2.16% |
| 2023-12-31 | CN¥1.97 Billion ≈ $288.71 Million |
+5.50% |
| 2022-12-31 | CN¥1.87 Billion ≈ $273.65 Million |
+5.05% |
| 2021-12-31 | CN¥1.78 Billion ≈ $260.49 Million |
+7.87% |
| 2020-12-31 | CN¥1.65 Billion ≈ $241.49 Million |
+1.16% |
| 2019-12-31 | CN¥1.63 Billion ≈ $238.73 Million |
+8.90% |
| 2018-12-31 | CN¥1.50 Billion ≈ $219.23 Million |
+8.31% |
| 2017-12-31 | CN¥1.38 Billion ≈ $202.40 Million |
+202.57% |
| 2016-12-31 | CN¥457.14 Million ≈ $66.89 Million |
+46.16% |
| 2015-12-31 | CN¥312.77 Million ≈ $45.77 Million |
+60.19% |
| 2014-12-31 | CN¥195.25 Million ≈ $28.57 Million |
+49.59% |
| 2013-12-31 | CN¥130.52 Million ≈ $19.10 Million |
-8.04% |
| 2012-12-31 | CN¥141.94 Million ≈ $20.77 Million |
+6.49% |
| 2011-12-31 | CN¥133.29 Million ≈ $19.50 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Shanghai Rongtai Health Tech's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 2500.8% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥1.18 Billion | 58.53% |
| Common Stock | CN¥177.38 Million | 8.81% |
| Other Comprehensive Income | CN¥179.45 Million | 8.91% |
| Other Components | CN¥478.37 Million | 23.75% |
| Total Equity | CN¥2.01 Billion | 100.00% |
Shanghai Rongtai Health Tech Competitors by Market Cap
The table below lists competitors of Shanghai Rongtai Health Tech ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Mersen SA
PA:MRN
|
$656.18 Million |
|
Zhejiang Jianye Chemical Co Ltd
SHG:603948
|
$656.25 Million |
|
Arko Corp
NASDAQ:ARKO
|
$656.33 Million |
|
Tyntek Corp
TW:2426
|
$656.35 Million |
|
SG Corporation
KO:004060
|
$655.93 Million |
|
Afcon Holdings Ltd
TA:AFHL
|
$655.87 Million |
|
AmRest Holdings SE
MC:EAT
|
$655.85 Million |
|
Mnc Land Tbk
JK:KPIG
|
$655.34 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Shanghai Rongtai Health Tech's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 1,968,889,002 to 2,014,115,666, a change of 45,226,664 (2.3%).
- Net income of 191,945,865 contributed positively to equity growth.
- Dividend payments of 199,818,824 reduced retained earnings.
- Other comprehensive income increased equity by 179,445,948.
- Other factors decreased equity by 126,346,325.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥191.95 Million | +9.53% |
| Dividends Paid | CN¥199.82 Million | -9.92% |
| Other Comprehensive Income | CN¥179.45 Million | +8.91% |
| Other Changes | CN¥-126.35 Million | -6.27% |
| Total Change | CN¥- | 2.30% |
Book Value vs Market Value Analysis
This analysis compares Shanghai Rongtai Health Tech's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 2.19x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 23.58x to 2.19x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2011-12-31 | CN¥0.95 | CN¥22.30 | x |
| 2012-12-31 | CN¥0.99 | CN¥22.30 | x |
| 2013-12-31 | CN¥1.28 | CN¥22.30 | x |
| 2014-12-31 | CN¥1.88 | CN¥22.30 | x |
| 2015-12-31 | CN¥2.95 | CN¥22.30 | x |
| 2016-12-31 | CN¥4.30 | CN¥22.30 | x |
| 2017-12-31 | CN¥9.99 | CN¥22.30 | x |
| 2018-12-31 | CN¥10.64 | CN¥22.30 | x |
| 2019-12-31 | CN¥11.74 | CN¥22.30 | x |
| 2020-12-31 | CN¥12.12 | CN¥22.30 | x |
| 2021-12-31 | CN¥12.70 | CN¥22.30 | x |
| 2022-12-31 | CN¥13.76 | CN¥22.30 | x |
| 2023-12-31 | CN¥10.98 | CN¥22.30 | x |
| 2024-12-31 | CN¥10.18 | CN¥22.30 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Shanghai Rongtai Health Tech utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.53%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 12.02%
- • Asset Turnover: 0.43x
- • Equity Multiplier: 1.86x
- Recent ROE (9.53%) is below the historical average (19.08%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2011 | 14.02% | 5.61% | 1.49x | 1.68x | CN¥5.32 Million |
| 2012 | 4.86% | 2.07% | 1.37x | 1.71x | CN¥-7.15 Million |
| 2013 | 20.26% | 6.28% | 1.36x | 2.38x | CN¥13.08 Million |
| 2014 | 31.89% | 8.52% | 1.64x | 2.29x | CN¥42.27 Million |
| 2015 | 46.10% | 13.94% | 1.52x | 2.17x | CN¥111.75 Million |
| 2016 | 45.80% | 16.08% | 1.19x | 2.39x | CN¥161.52 Million |
| 2017 | 15.82% | 11.27% | 0.88x | 1.60x | CN¥79.49 Million |
| 2018 | 16.73% | 10.86% | 1.06x | 1.45x | CN¥100.24 Million |
| 2019 | 18.15% | 12.77% | 0.94x | 1.51x | CN¥132.69 Million |
| 2020 | 11.63% | 9.55% | 0.68x | 1.78x | CN¥27.06 Million |
| 2021 | 13.30% | 9.05% | 0.80x | 1.85x | CN¥58.70 Million |
| 2022 | 8.80% | 8.19% | 0.59x | 1.83x | CN¥-22.39 Million |
| 2023 | 10.30% | 10.93% | 0.55x | 1.72x | CN¥5.82 Million |
| 2024 | 9.53% | 12.02% | 0.43x | 1.86x | CN¥-9.47 Million |
Industry Comparison
This section compares Shanghai Rongtai Health Tech's net assets metrics with peer companies in the Leisure industry.
Industry Context
- Industry: Leisure
- Average net assets among peers: $513,469,954
- Average return on equity (ROE) among peers: 17.56%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Shanghai Rongtai Health Tech (603579) | CN¥2.75 Billion | 14.02% | 0.22x | $656.07 Million |
| China Bicycle Co Holdings Ltd (000017) | $309.40 Million | 5.79% | 0.19x | $413.48 Million |
| HL Corp Shenzhen (002105) | $571.98 Million | 8.01% | 1.54x | $363.89 Million |
| Goldlok Toys Holdings Guangdong Co Ltd (002348) | $1.24 Billion | 3.42% | 0.06x | $1.54 Billion |
| Guangdong Qunxing Toys Joint-Stock Co Ltd (002575) | $783.43 Million | 2.51% | 0.07x | $614.35 Million |
| Shanghai Yaoji Playing Card Co Ltd (002605) | $213.44 Million | 30.04% | 1.16x | $1.25 Billion |
| Xiamen Comfort Science&Technology Group Co Ltd (002614) | $185.72 Million | 47.48% | 2.05x | $525.73 Million |
| Guangzhou Pearl River Piano Group Co Ltd (002678) | $3.55 Billion | 4.80% | 0.35x | $1.19 Billion |
| Shifeng Cultural Development Co Ltd (002862) | $79.61 Million | 39.95% | 1.12x | $455.54 Million |
| Impulse Qingdao Health Tech Co Ltd (002899) | $181.15 Million | 33.61% | 2.14x | $730.57 Million |
| China Bicycle Co Holdings Ltd (200017) | $-1.99 Billion | 0.00% | 0.00x | $66.51 Million |
About Shanghai Rongtai Health Tech
Shanghai Rongtai Health Technology Corporation Limited, together with its subsidiaries, engages in the research, design, development, production, and sale of massage equipment under the Rongtai and Momoda brands in China and internationally. The company offers massage chairs and accessories, neck massagers, eye massagers, massage backrests, massage belts, foot massagers, massage pads, and handhel… Read more